Rate My Professor Jessica Davis

Dr. Davis specializes in clinical and translational research on soft tissue tumors, with particular focus on non-rhabdomyosarcoma soft tissue sarcomas, bone sarcomas, and pediatric mesenchymal neoplasms involving kinase gene alterations such as NTRK, RET, BRAF, and ALK. She has authored over 60 peer-reviewed publications, review articles, and book chapters, including invited contributions to the fifth editions of the World Health Organization Classifications of Bone and Soft Tissue Tumours, Paediatric Tumours, and Skin Tumors. Key publications include 'Expanding the Spectrum of Pediatric NTRK-rearranged Mesenchymal Tumors' (Am J Surg Pathol, 2019), 'Recurrent RET gene fusions in paediatric spindle mesenchymal neoplasms' (Histopathology, 2020), 'Novel BRAF gene fusions and activating point mutations in spindle cell sarcomas with histologic overlap with infantile fibrosarcoma' (Mod Pathol, 2021), 'ALK rearrangements in infantile fibrosarcoma-like spindle cell tumours of soft tissue and kidney' (Histopathology, 2022), and 'Mesenchymal neoplasms with NTRK and other kinase gene alterations' (Histopathology, 2022). She influences the field as a central pathology reviewer for the Children’s Oncology Group on NRSTS and bone sarcomas, steering committee member for bone tumors, pediatric representative on the College of American Pathologists Cancer Committee, and committees for USCAP and SPP. Dr. Davis contributes to NIH/NCI initiatives including CancerPathCHART and SEER ClinCORE, and serves as Vice President of SPPRITEs, a non-profit advancing pediatric sarcoma research. She has presented invited lectures at numerous regional, national, and international meetings and edits the bone/soft tissue section for Diagnostic Pathology.